Search research articles
Contact Us
Filters
Showing results (291-300 of 302) with videos related to
Page
of 31
Sort By:
JCO Global Oncology
|
June 13, 2024
Cancer Trials Ecosystem in India-Ready for Prime Time?
Arun K Mankan, Abhishek Shankar, Sewanti Limaye, et al.
International Journal of Clinical Practice
|
June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Indian Journal of Cancer
|
March 23, 2021
Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer
Joydeep Ghosh, Deepa S Joy Phillip, Jaya Ghosh, et al.
Cancer Medicine
|
November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India
Sumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Journal of Global Oncology
|
August 8, 2018
National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer
Supriya J Chopra, Ashwathy Mathew, Amita Maheshwari, et al.
BMJ Oncology
|
January 31, 2025
Under-representation of older Indian persons with cancer in clinical trials
Vanita Noronha, Vijay Patil, Nandini Menon, et al.
Frontiers in Oncology
|
September 27, 2021
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India
Jyoti Bajpai, George Abraham, Avanish P Saklani, et al.
The National Medical Journal of India
|
December 3, 2022
Cancer care continuum at a tertiary care centre in India during the Covid-19 pandemic and nationwide lockdown: Healthcare delivery through telemedicine
Anant Gokarn, Amit Joshi, Tabassum Wadasadawala, et al.
Clinical Breast Cancer
|
July 28, 2024
A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer
Rushabh Kothari, Maulik Doshi, P K Chaithanya, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 302) with videos related to
Sort By:
Page
of 31
JCO Global Oncology
|
June 13, 2024
Cancer Trials Ecosystem in India-Ready for Prime Time?
Arun K Mankan, Abhishek Shankar, Sewanti Limaye, et al.
International Journal of Clinical Practice
|
June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Indian Journal of Cancer
|
March 23, 2021
Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer
Joydeep Ghosh, Deepa S Joy Phillip, Jaya Ghosh, et al.
Cancer Medicine
|
November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India
Sumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Journal of Global Oncology
|
August 8, 2018
National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer
Supriya J Chopra, Ashwathy Mathew, Amita Maheshwari, et al.
BMJ Oncology
|
January 31, 2025
Under-representation of older Indian persons with cancer in clinical trials
Vanita Noronha, Vijay Patil, Nandini Menon, et al.
Frontiers in Oncology
|
September 27, 2021
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India
Jyoti Bajpai, George Abraham, Avanish P Saklani, et al.
The National Medical Journal of India
|
December 3, 2022
Cancer care continuum at a tertiary care centre in India during the Covid-19 pandemic and nationwide lockdown: Healthcare delivery through telemedicine
Anant Gokarn, Amit Joshi, Tabassum Wadasadawala, et al.
Clinical Breast Cancer
|
July 28, 2024
A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer
Rushabh Kothari, Maulik Doshi, P K Chaithanya, et al.
Page
of 31